These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5985033)

  • 21. [Orolingual dyskinesia caused by prolonged neuroplegic therapy].
    Fenyvesi T
    Orv Hetil; 1968 Sep; 109(39):2149-52. PubMed ID: 5716904
    [No Abstract]   [Full Text] [Related]  

  • 22. [Nil nocere. Dyskinetico-hypertensive side effects following Tonoquil].
    Hansen HW; van Zwieten PA
    Munch Med Wochenschr; 1969 Jan; 111(5):241-4. PubMed ID: 5819129
    [No Abstract]   [Full Text] [Related]  

  • 23. [Polygraphic study of the effect of concentration and voluntary motricity on late dyskinesias].
    Jus K; Jus A; Villeneuve A; Villeneuve R
    Ann Med Psychol (Paris); 1972 Jun; 2(1):49-64. PubMed ID: 4565973
    [No Abstract]   [Full Text] [Related]  

  • 24. [Depression syndrome in the course of neuroleptic therapy].
    Helmchen H; Hippius H
    Nervenarzt; 1967 Oct; 38(10):455-8. PubMed ID: 6052776
    [No Abstract]   [Full Text] [Related]  

  • 25. [Facial dyskinesias caused by phenothiazine derivatives].
    De Oya JC; Alvarez Prechous A; Del Río A; Noya M; Ansede A
    Rev Clin Esp; 1971 May; 121(4):357-60. PubMed ID: 5563111
    [No Abstract]   [Full Text] [Related]  

  • 26. [The neuroleptic syndrome].
    Ostaptzeff G; Ostaptzeff-Lavoine M
    Ann Med Psychol (Paris); 1970 Nov; 2(4):614-7. PubMed ID: 5503374
    [No Abstract]   [Full Text] [Related]  

  • 27. [Post-neuroleptic late dyskinesia].
    Villeneuve A; Lavallée JC; Lemieux LH
    Laval Med; 1969 Nov; 40(9):832-7. PubMed ID: 5366584
    [No Abstract]   [Full Text] [Related]  

  • 28. [Complex persisting dyskinesia, secondary to neuroleptic therapy].
    Castaigne P; Lapresle J; Chain F
    Rev Neurol (Paris); 1969 Mar; 120(3):215-9. PubMed ID: 5343991
    [No Abstract]   [Full Text] [Related]  

  • 29. [Oral hyperkinesis].
    Bogolepov NK; Fleĭs EP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1971 Dec; 71(12):1761-5. PubMed ID: 5143958
    [No Abstract]   [Full Text] [Related]  

  • 30. A survey of extrapyramidal manifestations in the inpatient population of a psychiatric hospital.
    Lehmann HE; Ban TA; Saxena BM
    Laval Med; 1970 Sep; 41(7):909-16. PubMed ID: 5509489
    [No Abstract]   [Full Text] [Related]  

  • 31. [Delayed dyskinesias due to neuroleptics].
    Bourgeois M; Hébert A
    Bord Med; 1970 Feb; 3(2):345-52. PubMed ID: 5425869
    [No Abstract]   [Full Text] [Related]  

  • 32. Extrapyramidal and other effects induced by neuroleptic agents.
    Gunn DR
    Int J Neuropsychiatry; 1967 Aug; 3():Suppl 1:130-40. PubMed ID: 6051719
    [No Abstract]   [Full Text] [Related]  

  • 33. [Extrapyramidal movement disorders caused by low doses of Frenolon].
    Bencze J
    Fogorv Sz; 1966 Sep; 59(9):273-6. PubMed ID: 5223437
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of withdrawal of antiparkinsonian medication on chronically hospitalized psychiatric patients.
    Ananth JV; Horodesky S; Lehmann HE; Ban TA
    Laval Med; 1970 Sep; 41(7):934-8. PubMed ID: 5509491
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pseudotetanus following phenothiazine therapy].
    Matthes H; Andree G
    Zentralbl Chir; 1968 Jan; 93(4):147-9. PubMed ID: 5658295
    [No Abstract]   [Full Text] [Related]  

  • 36. Acute reversible neurological manifestations due to triflupromazine therapy. A report of three cases.
    Doshi HV; Shah SS; Mehta RM
    Indian J Med Sci; 1972 Jun; 26(6):395-8. PubMed ID: 4644887
    [No Abstract]   [Full Text] [Related]  

  • 37. [Extrapyramidal motoric symptoms and EEG changes following application of phenothiazine derivatives].
    Schiefer I
    Arch Kinderheilkd; 1971 Jul; 183(2):163-70. PubMed ID: 5567031
    [No Abstract]   [Full Text] [Related]  

  • 38. [Persistent extrapyramidal oral dyskinesia following administration of thymoleptics].
    Sedivec V; Valenová Z; Paceltová L
    Cesk Psychiatr; 1969 Aug; 65(4):241-4. PubMed ID: 5807247
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hypogeusia and dyskinesia as adverse drug effects].
    Rabe F
    Med Welt; 1970 Apr; 16():711-5. PubMed ID: 5445117
    [No Abstract]   [Full Text] [Related]  

  • 40. [Withdrawal symptoms after abrupt removal of psychopharmacotics as criteria to their differentiation. Remark on the essay of R. Battegay].
    Degkwitz R
    Nervenarzt; 1966 Dec; 37(12):556. PubMed ID: 5982949
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.